WASHINGTON — A dispute about the size of eye drops has failed to catch the eye of the Supreme Court.

Drug companies including Allergan, Bausch & Lomb, Merck and Pfizer had asked the court to get involved in the case. The companies were sued by patients using their eye drops to treat glaucoma and other eye conditions. The high court said Monday it won’t take the case, so a lower-court decision allowing the suit to go forward will stand.

The patients said that drug companies’ bottles dispense drops that are too large, leaving wasted medication running down their faces. The patients said they would pay less for their treatment if their bottles were designed to dispense smaller drops.

Companies argued the suit doesn’t belong in federal court.


Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.